Phase 3 AURA 1 trial meets primary endpoint paving way for new treatment option in China...
Regulatory milestone supports China’s reproductive health goals by enabling radiation-free, high-accuracy ultrasound imaging to assess fallopian tube patency and uterine abnormalities in women. ...
In-Depth Market Analysis Featuring Key Players Including Peijia Medical, HeMo Bioengineering, MicroPort NeuroTech, Zylox-Tonbridge, and Others – ResearchAndMarkets.com...
Strategic collaboration aims to expand access to advanced genomic testing and personalized cancer care for broader patient populations nationwide....
Regulatory clearance marks strategic expansion of ZYLOX’s innovative vascular technology in Southeast Asia....
Next-Generation Patient Monitoring System Introduces Advanced Intelligence and Seamless Connectivity for Smarter Critical Care...
Align Technology’s non-invasive orthodontic innovation set to transform pediatric care in China....
Company Expands Regional Presence with Focus on Medical Innovation and Infrastructure Development...
Cross-Border Collaboration Highlights Progress in Minimally Invasive Tumor Treatment Innovations...
Guangzhou & Shenzhen Events Showcase Innovation in Microwave Ablation for Precision Treatment...
